People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vascular Pathways Inc | — | Other | Series A | $23.6M | $83.7M | 2014 |
| Bioimagene Inc | — | Biotechnology | Series A | $12.0M | $433.8M | 2009 |
Matthew Hermann at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Hermann on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yatin Mundkur | 1 | 7 |
| G. Steven Burrill | 1 | 7 |
| Bosun Hau | 1 | 6 |
| Myles Greenberg | 1 | 6 |
| Amir Belson | 1 | 6 |
| Ajit Singh | 1 | 5 |
| John Dean | 1 | 5 |
| Joseph Keegan | 1 | 4 |
| Alan Weinstein | 1 | 2 |
| Vivek Pathak | 1 | 1 |
| Alan T. Weinstein | 1 | 1 |
| William Bold | 1 | 1 |
| Eugene T. Starr | 1 | 1 |
| Stephen T. Reeders | 1 | 1 |
| Walter T. Lin | 1 | 1 |
| Myles T. Greenberg | 1 | 1 |
| Amir T. Belson | 1 | 1 |
| Mohan Uttarwar | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.